HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Yonemori Selected Research

4-(4-methylcyclohexyl)-4-oxobutyric acid

9/2005Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Yonemori Research Topics

Disease

2Diabetes Complications
09/2005 - 06/2000
1Glucose Intolerance
09/2005
1Cataract (Cataracts)
09/2005
1Atherosclerosis
07/2000
1Type 2 Diabetes Mellitus (MODY)
06/2000
1Metabolic Bone Diseases (Osteopenia)
06/2000
1Stroke (Strokes)
01/2000
1Brain Ischemia (Cerebral Ischemia)
01/2000
1Neurologic Manifestations (Neurological Manifestations)
01/2000
1Paresis (Hemiparesis)
01/2000

Drug/Important Bio-Agent (IBA)

1Blood Glucose (Blood Sugar)IBA
09/2005
14-(4-methylcyclohexyl)-4-oxobutyric acidIBA
09/2005
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2005
1Cholesterol Ester Transfer ProteinsIBA
07/2000
1HDL CholesterolIBA
07/2000
1PPAR-gamma AgonistsIBA
06/2000
1Troglitazone (Rezulin)FDA Link
06/2000
1JTT 501IBA
06/2000
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2000
1PPAR alphaIBA
06/2000
1PPAR gammaIBA
06/2000
1JTP 2942IBA
01/2000
1Cytidine Diphosphate Choline (Citicoline)IBA
01/2000
1prolinamideIBA
01/2000
1Thyrotropin-Releasing Hormone (Protirelin)FDA Link
01/2000